MedTrace Logo

A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

NCT03073486 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 744

Last updated 2021-07-20

Study results available
· View outcomes & findings →

Summary

The objectives of this study are to assess the safety and efficacy of Olumacostat Glasaretil Gel compared to vehicle in patients with acne vulgaris

Conditions

  • Acne Vulgaris

Interventions

DRUG

Olumacostat Glasaretil Gel, 5.0%

Gel containing Olumacostat Glasaretil

OTHER

Olumacostat Glasaretil Gel, Vehicle

Vehicle (placebo) gel

Sponsors & Collaborators

  • Dermira, Inc.

    lead INDUSTRY

Principal Investigators

  • Beth Zib · Dermira, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
9 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-06
Primary Completion
2017-12-21
Completion
2017-12-21
FDA Drug
Yes

Countries

  • United States
  • Australia
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03073486 on ClinicalTrials.gov